Molecular Insights for Harnessing Urine Biomarkers in Precision Medicine

Cheng Xue, currently serving as a Medical Doctor in the Department of Nephrology at Shanghai Changzheng Hospital affiliated with Naval Medical University, holds the position of Deputy Chief Physician. He contributes significantly to the medical community through various editorial roles, including Guest Associate Editor at Frontiers of Nephrology and serving on the editorial boards of Urine, Journal of Clinical Nephrology, and JTIM.With an impressive publication record, Cheng Xue has authored 55 papers indexed in SCI journals and 23 papers in prominent Chinese journals, including NEJM, JASN, KI, AJKD, NDT, among others. His research spans across leading medical publications, demonstrating his expertise and contribution to the field.Furthermore, Cheng Xue has led significant research projects, including hosting a National Natural Science Foundation project and a China Postdoctoral Science Foundation project. His innovative work has resulted in the acquisition of 11 national patents, reflecting his dedication to advancing medical science and improving patient care.Dr. Jing Xu, M.D., Ph.D., is an esteemed Associate Professor in the Department of Nephrology at Shanghai Changzheng Hospital. With extensive expertise, she specializes in diagnosing and treating both acute and chronic kidney dysfunction stemming from conditions such as chronic glomerulonephritis, diabetes, and hypertension. Dr. Xu excels in managing critical nephropathy using various blood purification methods, including intermittent hemodialysis, bedside continuous renal replacement therapy, and peritoneal dialysis. Her proficiency extends to establishing access for these therapies.Dr. Xu's dedication to advancing knowledge in nephrology is evident through her research focus on decoding the mechanisms of chronic kidney fibrosis and persistent inflammation following acute kidney injury, particularly centering on the Hippo pathway and its components. Her contributions have been recognized with several grants from the National Science Foundation and the local medical ministry.Furthermore, Dr. Xu has authored numerous research articles in prestigious journals such as CJASN, NDT, and CKJ, often as the (co-)first or (co-)correspondence author. Her commitment to academic excellence is further reflected in her role as a young committee member of several local nephrology academic communities.Bo Yang, MD, specializes in Internal Medicine III (Nephrology) at the Naval Medical Center of the People's Liberation Army (PLA), affiliated with the Second Military Medical University in Shanghai. Dr. Yang's expertise in nephrology contributes significantly to the medical care and research efforts at this esteemed institution.Lyu Jiayi, MD is Associate Chief Physician within the Department of Nephrology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, China. Dr. Jiayi received her PhD in Nephrology from Shanghai Changzheng Hospital and completed the Joint Ph.D. Training Program with the Mayo Clinic. Dr. Jiayi’s research is focused on pathogenesis, diagnosis, and treatment of autosomal dominant polycystic kidney disease (ADPKD) as well as clinical management of acute and chronic kidney diseases.

• Section I. Introduction1. Background and Significance and Historical Perspective of Urine Biomarkers in Medicine2. Rationale for Exploring Urine BiomarkersSection II. Fundamentals of Urine Biomarkers3. Definition and Types of Biomarkers4. Characteristics of Ideal Urine BiomarkersSection III. Molecular Signatures in Urine5. Cellular Components in Urine6. Genetic and Epigenetic Markers7. Proteomic and Metabolomic Signatures8. MicroRNA and Non-Coding RNA ProfilesSection IV. Urine Biomarkers Across Body Systems9. Renal System10. Urological System11. Cardiovascular System12. Endocrine System13. Musculoskeletal System14. Immune System15. Respiratory System16. Blood system17. Digestive system18. J. Nervous systemSection V. Techniques for Urine Biomarker Detection19. Laboratory Techniques20. Point-of-Care TestingSection VI. Clinical Implications and Applications21. Diagnosis and Prognosis22. Monitoring Disease Progression23. Treatment Response Assessment24. Personalized Medicine ApproachesSection VII. Challenges and Limitations25. Standardization Issues26. Variability in Urine Composition27. Ethical Considerations28. Cost-effectivenessSection VIII. Future Directions and Emerging Trends29. Advances in Technology30. Integration with Other Diagnostic Modalities31. Potential Therapeutic TargetsSection IX. Case Studies32. Real-world Applications of Urine Biomarkers33. Success Stories and Lessons LearnedSection X. Conclusion34. Implications for Future Research and Clinical Practice35. Summary of Key Findings